New clinical trial data showed a new drug can slow cognitive decline in Alzheimer's patients, potentially paving the way for a drug to hit the U.S. market next year.
New clinical trial data showed a new drug can slow cognitive decline in Alzheimer’s patients, potentially paving the way for a drug to hit the U.S. market next year.
